What is Paclitaxel?

Category: Prescription Drugs

Most popular types: Taxol Abraxane

false

See also: Doxorubicin-cyclophosphamide-paclitaxel (ACT) Doxorubicin-cyclphophosphamide-paclitaxel-trastuzumab (AC-TH) Doxorubicin-cyclphophosphamide-paclitaxel-trastuzumab-pertuzumab (AC-THP) Gemcitabine-paclitaxel Paclitaxel-bevacizumab Paclitaxel-trastuzumab-carboplatin Paclitaxel-trastuzumab-pertuzumab (THP) Paclitaxel-trastuzumab (TH)

Paclitaxel is an anticancer drug used in the treatment of breast, nonsmall cell lung, and ovarian cancers; and AIDS-related Kaposi's sarcoma. It has also been used for bladder, cervical, small cell lung, and head and neck cancers.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Ovarian cancer 267 5
Endometrial cancer 27 5
Breast cancer 12 4
Stomach cancer 9 0
Lung cancer 4 3
Squamous cell carcinoma (non-small cell lung cancer) 3 0

Show all 13 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 5
Moderate 6
Mild 8
None 1

Commonly reported side effects and conditions associated with Paclitaxel

Side effect Patients Percentage
Hair loss 7
Fatigue 4
Diarrhea 2
Breathing difficulty 1
Chest tightness 1
Eyebrow thinning 1

Show all 23 reported side effects

Why patients stopped taking Paclitaxel

Multiple reasons could be selected

Reason Patients Percentage
Course of treatment ended 15
Doctor's advice 3
Did not seem to work 2
Other 1
Side effects too severe 1
See all 19 patients who've stopped taking Paclitaxel

Duration

Currently taking Paclitaxel

Duration Patients Percentage
6 months - 1 year 1

Stopped taking Paclitaxel

Duration Patients Percentage
Less than 1 month 2
1 - 6 months 15
6 months - 1 year 1
2 - 5 years 1
Adherence
Adherence Evaluations Percentage
Always 15
Usually 3
Sometimes 2
Never taken as prescribed 0
Burden
Burden Evaluations Percentage
Very hard to take 3
Somewhat hard to take 5
A little hard to take 7
Not at all hard to take 5
Cost per month
Cost per month Evaluations Percentage
$200+ 1
$100-199 1
$50-99 0
$25-49 0
< $25 8
Not specified 10

What people switch to and from

Patients started taking Paclitaxel after stopping:

Treatment Patients Percentage
Cyclophosphamide (Cytoxan) 1
Pemetrexed (Alimta) 1

Patients stopped taking Paclitaxel and switched to:

Treatment Patients Percentage
Abemaciclib (Verzenio) 1
Bevacizumab (Avastin) 1
Eribulin (Halaven) 1
Lenvatinib (Lenvima) 1
Nivolumab (Opdivo) 1

Show all 8 treatments patients report switching to

Last updated:

1 patient evaluation for Paclitaxel

Jul 14, 2014 (Started Mar 20, 2014)

  • Effectiveness
    Major (for breast cancer)
  • Side effects
    Moderate (fatigue)
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 30 mg Weekly
Advice & Tips: Same effect on RA.

  • 0 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for Paclitaxel